Developer of human gene-based therapies. The company has developed a platform to bring new disease-modifying therapies to patients with severe disorders. The company's pipeline includes gene-based therapies for lipoprotein lipase deficiency, or LPLD, Sanfilippo B, Parkinson's Disease and Hemophilia B.read more
Robert Gut ā Member of the Board of Directors at uniQure
Executive Bio
Robert Gut serves as the Member of the Board of Directors of uniQure. Robert started at uniQure in June of 2018. Robert currently resides in Greater Boston Area.
Executive Team Culture Ratings from uniQure Employees
TOP
10%
uniQure's Executive Team scores in the Top 10% of similar sized companies on Comparably